Livopill UD Tablet contains Ursodeoxycholic Acid 300 mg, a hydrophilic bile acid used primarily in the treatment of various hepatobiliary disorders. Ursodeoxycholic Acid acts by reducing the cholesterol content of bile and bile stones, thereby promoting the dissolution of cholesterol gallstones in patients with a functioning gallbladder. Additionally, it improves bile flow and reduces hepatocellular damage by stabilizing cell membranes and exerting cytoprotective effects. Livopill UD is indicated for the management of primary biliary cholangitis, intrahepatic cholestasis, and certain cases of chronic liver diseases where bile flow is impaired. It is also utilized to prevent the formation of cholesterol gallstones in high-risk patients. The tablet should be administered orally, typically once or twice daily, with dosage adjusted according to the patient’s condition and response to therapy. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, or abdominal discomfort, which are generally mild and transient. Caution is advised in patients with biliary obstruction or acute inflammation of the gallbladder. Regular monitoring of liver function tests is recommended during prolonged therapy to assess efficacy and detect potential adverse effects. Livopill UD Tablet should be used under medical supervision to ensure optimal therapeutic outcomes.